Mark Hill

8.1k total citations · 1 hit paper
107 papers, 5.4k citations indexed

About

Mark Hill is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mark Hill has authored 107 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Oncology, 36 papers in Pulmonary and Respiratory Medicine and 35 papers in Surgery. Recurrent topics in Mark Hill's work include Colorectal Cancer Treatments and Studies (36 papers), Gastric Cancer Management and Outcomes (21 papers) and Colorectal and Anal Carcinomas (14 papers). Mark Hill is often cited by papers focused on Colorectal Cancer Treatments and Studies (36 papers), Gastric Cancer Management and Outcomes (21 papers) and Colorectal and Anal Carcinomas (14 papers). Mark Hill collaborates with scholars based in United Kingdom, United States and Australia. Mark Hill's co-authors include David Cunningham, A. Norman, Samuel H. Preston, Ira Rosenwaike, Timothy Price, Ian Chau, Paul J. Ross, Filippo de Braud, Hans‐Joachim Schmoll and Josep Tabernero and has published in prestigious journals such as Journal of Clinical Oncology, Analytical Chemistry and American Sociological Review.

In The Last Decade

Mark Hill

107 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer

2011 533 citations Daniel G. Haller, Josep Tabernero et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Hill United Kingdom	39	3.0k	1.5k	1.5k	744	492	107	5.4k
Pascale Grosclaude France	36	2.5k 0.8×	1.2k 0.8×	1.1k 0.7×	515 0.7×	182 0.4×	206	5.7k
Ian Olver Australia	50	2.7k 0.9×	1.5k 1.0×	1.1k 0.8×	525 0.7×	621 1.3×	342	8.8k
Mats Lambe Sweden	62	4.9k 1.7×	1.5k 1.0×	2.5k 1.7×	608 0.8×	284 0.6×	293	12.0k
Theo Wobbes Netherlands	41	1.7k 0.6×	1.3k 0.9×	835 0.6×	1.1k 1.5×	452 0.9×	132	5.1k
Barry A. Miller United States	26	2.2k 0.7×	398 0.3×	561 0.4×	273 0.4×	272 0.6×	40	3.9k
Frederick L. Moffat United States	28	1.7k 0.6×	1.5k 1.0×	743 0.5×	1.6k 2.1×	330 0.7×	73	4.8k
Charles L. Wiggins United States	36	2.5k 0.8×	662 0.4×	761 0.5×	303 0.4×	209 0.4×	113	5.0k
Katherine S. Virgo United States	50	4.7k 1.6×	2.5k 1.7×	3.1k 2.1×	694 0.9×	395 0.8×	203	10.9k
Corinne R. Leach United States	25	3.5k 1.2×	463 0.3×	1.3k 0.9×	329 0.4×	438 0.9×	60	6.1k
Galina Velikova United Kingdom	53	6.3k 2.1×	1.3k 0.9×	1.9k 1.3×	401 0.5×	881 1.8×	254	10.8k

Countries citing papers authored by Mark Hill

Since Specialization

Citations

This map shows the geographic impact of Mark Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hill more than expected).

Fields of papers citing papers by Mark Hill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hill. The network helps show where Mark Hill may publish in the future.

Co-authorship network of co-authors of Mark Hill

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Hill. A scholar is included among the top collaborators of Mark Hill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Hill. Mark Hill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Itsumura, Naoya, et al.. (2021). Cost-effectiveness of baloxavir marboxil compared with laninamivir for the treatment of influenza in patients at high risk for complications in Japan. Current Medical Research and Opinion. 37(7). 1135–1148. 7 indexed citations

Taieb, V., et al.. (2020). Efficacy and safety of baloxavir marboxil versus neuraminidase inhibitors in the treatment of influenza virus infection in high-risk and uncomplicated patients – a Bayesian network meta-analysis. Current Medical Research and Opinion. 37(2). 225–244. 21 indexed citations

Middleton, Gary, Sarah Brown, Catherine Lowe, et al.. (2013). A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO). European Journal of Cancer. 49(16). 3507–3516. 19 indexed citations

Raouf, Sherif, John Bridgewater, Richard Ellis, et al.. (2012). Use of bevacizumab in the treatment of metastatic colorectal cancer. British Journal of Hospital Medicine. 73(1). 25–30. 1 indexed citations

Haller, Daniel G., Josep Tabernero, Jean A. Maroun, et al.. (2011). Capecitabine Plus Oxaliplatin Compared With Fluorouracil and Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer. Journal of Clinical Oncology. 29(11). 1465–1471. 533 indexed citations breakdown →

Hill, Mark, et al.. (2006). The Role of the Epidermal Growth Factor Receptor in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia. 11(1). 3–11. 56 indexed citations

Hill, Mark, et al.. (2005). One-gland exploration for mediastinal parathyroid adenomas: cervical and thoracoscopic approaches. The American Journal of Surgery. 189(5). 601–605. 14 indexed citations

Waters, Justin S., David Cunningham, Ian Chau, et al.. (2005). Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma. British Journal of Cancer. 92(8). 1352–1357. 42 indexed citations

Mackay, Helen, Mark Hill, Chris Twelves, et al.. (2003). A phase I/II study of oral uracil/tegafur (UFT), leucovorin and irinotecan in patients with advanced colorectal cancer. Annals of Oncology. 14(8). 1264–1269. 28 indexed citations

10.

Chau, Ian, et al.. (2003). Impact of 5-Fluorouracil Rechallenge on Subsequent Response and Survival in Advanced Colorectal Cancer: Pooled Analysis from Three Consecutive Randomized Controlled Trials. Clinical Colorectal Cancer. 3(2). 102–107. 9 indexed citations

11.

Saini, Andrea, A. Norman, David Cunningham, et al.. (2003). Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancer. British Journal of Cancer. 88(12). 1859–1865. 61 indexed citations

12.

Paull, Daniel L., et al.. (2002). Endoscopic greater saphenous vein harvesting reduces the morbidity of coronary artery bypass surgery. The American Journal of Surgery. 183(5). 576–579. 33 indexed citations

13.

Holmes, James H., Daniel L. Paull, Mark Hill, et al.. (2002). Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflammation Research. 51(12). 579–586. 96 indexed citations

14.

Ford, Hugo, David Cunningham, David Farrugia, et al.. (2002). Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331.. PubMed. 8(1). 103–9. 32 indexed citations

15.

Waters, Justin S., Diana Tait, David Cunningham, et al.. (2002). A multicentre phase II trial of primary chemotherapy with cisplatin and protracted venous infusion 5-fluorouracil followed by chemoradiation in patients with carcinoma of the oesophagus. Annals of Oncology. 13(11). 1763–1770. 9 indexed citations

16.

Chau, Ian, Andrew Webb, David Cunningham, et al.. (2001). Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer. British Journal of Cancer. 85(9). 1258–1264. 20 indexed citations

17.

Hill, Mark. (2000). Color Differences in the Socioeconomic Status of African American Men: Results of a Longitudinal Study. Social Forces. 78(4). 1437–1460. 119 indexed citations

18.

Hill, Mark, et al.. (1997). Taxane/platinum/anthracycline combination therapy in advanced epithelial ovarian cancer.. PubMed. 24(1 Suppl 2). S2–34. 13 indexed citations

19.

Hill, Mark, S Milan, David Cunningham, et al.. (1995). Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity.. Journal of Clinical Oncology. 13(2). 387–395. 37 indexed citations

20.

Hill, Mark, W. M. Lougheed, & H. J. M. Barnett. (1967). A treatable form of dementia due to normal-pressure, communicating hydrocephalus.. PubMed Central. 97(22). 1309–20. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact